Technology
VenoStent has a new technology to improve outcomes for dialysis patients – Yahoo Lifestyle Australia
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients. Failed dialysis surgeries occur …
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
Failed dialysis surgeries occur in roughly 55% to 65% of patients with end-stage renal disease, according to the company. Caring for these patients can cost the Medicare and Medicaid Services system roughly $2 billion per year — and Bouré and Lucks believed that they’d co…
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News23 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
General13 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people